SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration Under
Section 12(g) of the Securities Exchange Act of 1934 or Suspension
of Duty to File Reports Under Sections 13 and 15(d) of the
Securities Exchange Act of 1934.
Commission File Number 000-21727
SeaMED Corporation
(Exact name of registrant as specified in its charter)
21620 30th Avenue SE, Bothell WA 98021
Telephone: (425) 482-1300
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
Common Stock, No Par Value
Preferred Stock Purchase Rights
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to
file reports under Sections 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate
rule provision(s) relied upon to terminate or suspend the duty to
file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii)[ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii)[ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification
of or notice date: 1(1)
____________________
1Effective July 23, 1999, SeaMED was merged with a wholly owned
subsidiary of Plexus Corp. (Commission File No. 000-14824) in a
merger in which all of the outstanding shares of SeaMED Corporation
Common Stock were converted into shares of Plexus Common Stock
(except for fractional share interests paid in cash), and the
registrant became a wholly owned subsidiary of Plexus. SeaMED's
Preferred Stock Purchase Rights were redeemed by SeaMED prior to the
merger.
Pursuant to the requirements of the Securities Exchange Act of
1934, SeaMED Corporation has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
DATE: July 23, 1999 BY: /s/ Jos. D. Kaufman
Joseph D. Kaufman, Secretary
